Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study

Leuk Lymphoma. 2017 Nov;58(11):2752-2754. doi: 10.1080/10428194.2017.1312385. Epub 2017 May 9.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Aplastic / blood
  • Anemia, Aplastic / complications*
  • Anemia, Aplastic / diagnosis
  • Anemia, Aplastic / therapy
  • Blood Transfusion*
  • Chelation Therapy
  • Female
  • Hematologic Neoplasms / blood
  • Hematologic Neoplasms / complications*
  • Hematologic Neoplasms / diagnosis
  • Hematologic Neoplasms / therapy
  • Humans
  • Iron Chelating Agents / administration & dosage
  • Iron Chelating Agents / therapeutic use*
  • Iron Overload / diagnosis
  • Iron Overload / drug therapy*
  • Iron Overload / etiology*
  • Male
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Iron Chelating Agents